CEL-SCI Corp Talks Phase 3 Head and Neck Cancer Study, Immunotherapy for COVID-19 in Corporate Update Transcript
This is Robert Kraft, and I'm your host on SNN Network. And joining me today is Geert Kersten. He is the CEO of CEL-SCI Corporation, a publicly traded company. The symbol is CVM on the NYSE American. Geert, good to see you again. How are you doing?
We're doing well, thank you. And it's good to see you again, video though. Not of course --
It's good to see you too. It's been a while as we'll get to in a minute. So first things first. How's everyone holding up? How's the family? Everyone healthy, safe?
Everybody is fine. Thank you. the dog loves it. It is interesting though how certain habits have changed. I see the needs for all this continuous travel diminish.
Geert, I got to say, and I joked with you
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
